In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates
- 1 January 1999
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 33 (1) , 27-31
- https://doi.org/10.1016/s0732-8893(98)00129-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteriaJournal of Antimicrobial Chemotherapy, 1997
- In vitro activity of Bay 12-8039, a new 8-methoxyquinoloneAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humansAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of BAY 12-8039, a new fluoroquinoloneAntimicrobial Agents and Chemotherapy, 1997
- In vitro Activity of BAY 12-8039, a New 8-MethoxyquinoloneChemotherapy, 1996